21.05.2016 Views

Assessment report

22iIUw4

22iIUw4

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Test and reference products<br />

Certificates of analysis of the test and reference product were provided by the applicant. The batch size<br />

of the test product (190 000 Units) was considered acceptable by the CHMP.<br />

The applicant confirmed that the composition and manufacturing process of the test product<br />

formulation used in the bio-equivalence study and the formulation proposed for commercial supplies to<br />

the European Economic Area is the same.<br />

The CHMP noted, that the location of Certificate of Analysis given by the applicant in the table above<br />

was incorrect and should be revised.<br />

Population(s) studied<br />

The study was conducted in Asian male population. The 60 subjects (male) who participated in this<br />

study were healthy, in the age range of 45 to 60 years (mean age 50 years), a weight range of 45.6 to<br />

84.2 kg (mean weight 61.1 kg), a height range of 146.0 to 180.0 cm (mean height 163.9 cm) and<br />

Body Mass Index (BMI) range of 18.7 to 29.3 kg/m2 (mean BMI 22.7 kg/m 2 ).<br />

A total of 47 healthy, adult, human subjects in Group-I and 31 in Group-II meeting the inclusion and<br />

exclusion criteria as mentioned in the protocol were enrolled in to the study to ensure the dosing of<br />

60 subjects.<br />

<strong>Assessment</strong> <strong>report</strong><br />

EMA/49072/2016 Page 16/37

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!